Trial Site Detail

 

Drug:	IPI-504
Trial:	Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Terminated

 

Washington Cancer Institute 110 Irving St      Washington , DC 20010 USA

 

Principal Investigator:	Denis Preibat, MD
Contact:	Christina Sheeran 202-877-9386 christina.m.sheeran@medstar.net
Activation Status of this Site:	Closed
Notes about this Site:
Washington Cancer Institute Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.